Italia markets closed

BMY Oct 2024 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,16000,0000 (0,00%)
In data: 01:25PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1600
Aperto0,1600
Denaro0,0500
Lettera0,3700
Prezzo d'esercizio62,50
Scadenza2024-10-18
Min-Max giorno0,1600 - 0,1600
Contratto - Min-MaxN/D
Volume1
Open Interest50
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri